Skip to content

Cytokines, POD, Health Status, Older Hip Fracture

Perioperative Cytokines, Postoperative Delirium and Health Status in Older People Undergoing Hip Fracture Surgery - a Pilot Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05096507
Enrollment
60
Registered
2021-10-27
Start date
2022-06-06
Completion date
2023-07-31
Last updated
2022-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fracture Surgery, Older People, Postoperative Delirium

Keywords

Postoperative delirium, Older people, Cytokines, Self-reported Health Status

Brief summary

An investigation of the change in inflammation marker levels across hip fracture surgery and an exploration of any association with change in self reported health status and incidence of postoperative delirium

Interventions

PROCEDUREHip fracture Surgery (Primary)

Surgery for primary hip fracture requiring general or neuro-axial anaesthesia

Sponsors

University of Nottingham
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 65 years old * Admitted for primary hip fracture surgery

Exclusion criteria

* Preoperative cognitive impairment * History of neurosurgery, neurologic diseases or head trauma * Current systemic bacterial or viral infection * Complex or multiple injuries

Design outcomes

Primary

MeasureTime frameDescription
Incidence of postoperative delirium5 daysAssessment for presence or absence of delirium during the post operative period.
Cytokine dynamics2 daysDifference preoperative serum cytokine levels and postoperative serum cytokine levels in pg/mL.

Secondary

MeasureTime frameDescription
Self reported health related quality of Life120 daysAssessed preoperatively and again at approximately 120 days after surgery using the EuroQol Five Dimension Five level (EQ-5D-5L) tool. The tool assesses on five aspects of health (Dimensions) and each dimension has five possible levels. The tool also has a visual analogue scale ranging from 0 (poorest) to 100 (best health)

Countries

United Kingdom

Contacts

Primary ContactAbiodun Noah, FRCA
abi.noah@nottingham.ac.uk01158231011
Backup ContactIain Moppett, DM
iain.moppett@nottingham.ac.uk01158230959

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026